Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Profit And Price Declaration Requirements Mar Otherwise Workable Vietnam Medtech Regulation

Executive Summary

Vietnam’s medtech industry breathed more easily when the new decree, 98/2021, became the regulatory instrument for the sector on 1 January. While its practical approach to industry’s needs was welcomed, new price and profit declaration demands will be harder for companies to swallow.

You may also be interested in...



Vietnam Medtech Regulation: CSDT Applies In 2022 But IVD Industry Wary Of Pharma Influence

Vietnam has adopted the ASEAN Common Submission Dossier Template and updated its medtech regulation to allow more compliance time for medtech manufacturers. But the IVD industry fears too much pharma influence in file auditing.

On-Prescription Apps Are Just One Vital Part Of Germany’s Digital Strategy

Are too few digital health care apps approved for reimbursement in Germany? That’s not the point, says the health care ministry, urging a look at the bigger strategic picture.

Swiss Parliament’s Vote For Medtech Innovation Succeeds

Another key stage has been reached in Switzerland’s bid to enable US FDA-approved medtech to be used in the local population.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145048

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel